Axonal transport and neurodegenerative disease: Can we see the elephant?

Progress in Neurobiology

Volumn 99, Issue 3, 2012, Pages 186-190

  Goldstein, Lawrence S B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SANFORD CONSORTIUM FOR REGENERATIVE MEDICINE   (United States)

Author keywords

Alzheimer's disease; Axonal transport; Dynein; Huntington's disease; Kinesin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; HUNTINGTIN; POLYGLUTAMINE; PRESENILIN; TAU PROTEIN;

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; ELEPHANT; EXON; GENE MUTATION; GOLGI COMPLEX; HUMAN; HUNTINGTON CHOREA; NERVE FIBER TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; REVIEW;

ANIMALS; AXONAL TRANSPORT; DISEASE PROGRESSION; DYNEINS; HUMANS; KINESIN; NEURODEGENERATIVE DISEASES;

EID: 84869861937     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2012.03.006     Document Type: Review

References (90)

1. Anne S.L., Saudou F., Humbert S. Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons. J. Neurosci. 2007, 27:7318-7328.
2. Bertram L., Lill C.M., Tanzi R.E. The genetics of Alzheimer disease: back to the future. Neuron 2010, 68:270-281.
3. Buxbaum J.D., Thinakaran G., Koliatsos V., O'Callahan J., Slunt H.H., Price D.L., Sisodia S.S. Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J. Neurosci. 1998, 18:9629-9637.
4. Cai D., Leem J.Y., Greenfield J.P., Wang P., Kim B.S., Wang R., Lopes K.O., Kim S.H., Zheng H., Greengard P., et al. Presenilin-1 regulates intracellular trafficking and cell surface delivery of beta-amyloid precursor protein. J. Biol. Chem. 2003, 278:3446-3454.
5. Calkins M.J., Reddy P.H. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons. Biochim. Biophys. Acta 2011, 1812:507-513.
6. Carey R.M., Balcz B.A., Lopez-Coviella I., Slack B.E. Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid beta protein. BMC Cell Biol. 2005, 6:30.
7. Caviston J.P., Holzbaur E.L. Huntingtin as an essential integrator of intracellular vesicular trafficking. Trends Cell Biol. 2009, 19:147-155.
8. Caviston J.P., Ross J.L., Antony S.M., Tokito M., Holzbaur E.L. Huntingtin facilitates dynein/dynactin-mediated vesicle transport. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10045-10050.
9. Caviston J.P., Zajac A.L., Tokito M., Holzbaur E.L. Huntingtin coordinates the dynein-mediated dynamic positioning of endosomes and lysosomes. Mol. Biol. Cell 2011, 22:478-492.
10. Chevalier-Larsen E., Holzbaur E.L. Axonal transport and neurodegenerative disease. Biochim. Biophys. Acta 2006, 1762:1094-1108.
11. Colin E., Zala D., Liot G., Rangone H., Borrell-Pages M., Li X.J., Saudou F., Humbert S. Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. EMBO J. 2008, 27:2124-2134.
12. Cottrell B.A., Galvan V., Banwait S., Gorostiza O., Lombardo C.R., Williams T., Schilling B., Peel A., Gibson B., Koo E.H., et al. A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease. Ann. Neurol. 2005, 58:277-289.
13. De Vos K.J., Grierson A.J., Ackerley S., Miller C.C. Role of axonal transport in neurodegenerative diseases. Annu. Rev. Neurosci. 2008, 31:151-173.
14. Decker H., Lo K.Y., Unger S.M., Ferreira S.T., Silverman M.A. Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons. J. Neurosci. 2010, 30:9166-9171.
15. Duncan J.E., Goldstein L.S. The genetics of axonal transport and axonal transport disorders. PLoS Genet. 2006, 2:e124.
16. Engelender S., Sharp A.H., Colomer V., Tokito M.K., Lanahan A., Worley P., Holzbaur E.L., Ross C.A. Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum. Mol. Genet. 1997, 6:2205-2212.
17. Evin G., Barakat A., Masters C.L. BACE: therapeutic target and potential biomarker for Alzheimer's disease. Int. J. Biochem. Cell Biol. 2010, 42:1923-1926.
18. Gauthier L.R., Charrin B.C., Borrell-Pages M., Dompierre J.P., Rangone H., Cordelieres F.P., De Mey J., MacDonald M.E., Lessmann V., Humbert S., et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 2004, 118:127-138.
19. Goldsbury C., Mocanu M.M., Thies E., Kaether C., Haass C., Keller P., Biernat J., Mandelkow E., Mandelkow E.M. Inhibition of APP trafficking by tau protein does not increase the generation of amyloid-beta peptides. Traffic 2006, 7:873-888.
20. Goldstein L.S. Do disorders of movement cause movement disorders and dementia?. Neuron 2003, 40:415-425.
21. Gunawardena S., Goldstein L.S. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 2001, 32:389-401.
22. Gunawardena S., Goldstein L.S. Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways. Arch. Neurol. 2005, 62:46-51.
23. Gunawardena S., Her L.S., Brusch R.G., Laymon R.A., Niesman I.R., Gordesky-Gold B., Sintasath L., Bonini N.M., Goldstein L.S. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 2003, 40:25-40.
24. Han I., You Y., Kordower J.H., Brady S.T., Morfini G.A. Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features. J. Neurochem. 2010, 113:1073-1091.
25. Her L.S., Goldstein L.S. Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin. J. Neurosci. 2008, 28:13662-13672.
26. Hiruma H., Katakura T., Takahashi S., Ichikawa T., Kawakami T. Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J. Neurosci. 2003, 23:8967-8977.
27. Horiuchi D., Barkus R.V., Pilling A.D., Gassman A., Saxton W.M. APLIP1, a kinesin binding JIP-1/JNK scaffold protein, influences the axonal transport of both vesicles and mitochondria in Drosophila. Curr. Biol. 2005, 15:2137-2141.
28. Inomata H., Nakamura Y., Hayakawa A., Takata H., Suzuki T., Miyazawa K., Kitamura N. A scaffold protein JIP-1b enhances amyloid precursor protein phosphorylation by JNK and its association with kinesin light chain 1. J. Biol. Chem. 2003, 278:22946-22955.
29. Israel M.A., Yuan S.H., Bardy C., Reyna S.M., Mu Y., Herrera C., Hefferan M.P., Van Gorp S., Nazor K.L., Boscolo F.S., et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012, 482:216-220.
30. Jiang Y., Mullaney K.A., Peterhoff C.M., Che S., Schmidt S.D., Boyer-Boiteau A., Ginsberg S.D., Cataldo A.M., Mathews P.M., Nixon R.A. Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:1630-1635.
31. Kaether C., Haass C., Steiner H. Assembly, trafficking and function of gamma-secretase. Neurodegener. Dis. 2006, 3:275-283.
32. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., Goldstein L.S. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 2001, 414:643-648.
33. Kamal A., Stokin G.B., Yang Z., Xia C.H., Goldstein L.S. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 2000, 28:449-459.
34. Kasa P., Papp H., Kovacs I., Forgon M., Penke B., Yamaguchi H. Human amyloid-beta1-42 applied in vivo inhibits the fast axonal transport of proteins in the sciatic nerve of rat. Neurosci. Lett. 2000, 278:117-119.
35. Kasa P., Papp H., Pakaski M. Presenilin-1 and its N-terminal and C-terminal fragments are transported in the sciatic nerve of rat. Brain Res. 2001, 909:159-169.
36. Koo E.H., Squazzo S.L. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J. Biol. Chem. 1994, 269:17386-17389.
37. Lasiecka Z.M., Winckler B. Mechanisms of polarized membrane trafficking in neurons-focusing in on endosomes. Mol. Cell. Neurosci. 2011.
38. Lazarov O., Lee M., Peterson D.A., Sisodia S.S. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J. Neurosci. 2002, 22:9785-9793.
39. Lazarov O., Morfini G.A., Lee E.B., Farah M.H., Szodorai A., DeBoer S.R., Koliatsos V.E., Kins S., Lee V.M., Wong P.C., et al. Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J. Neurosci. 2005, 25:2386-2395.
40. Lazarov O., Morfini G.A., Pigino G., Gadadhar A., Chen X., Robinson J., Ho H., Brady S.T., Sisodia S.S. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J. Neurosci. 2007, 27:7011-7020.
41. Lee E.B., Zhang B., Liu K., Greenbaum E.A., Doms R.W., Trojanowski J.Q., Lee V.M. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo. J. Cell Biol. 2005, 168:291-302.
42. Lee J.H., Yu W.H., Kumar A., Lee S., Mohan P.S., Peterhoff C.M., Wolfe D.M., Martinez-Vicente M., Massey A.C., Sovak G., et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 2010, 141:1146-1158.
43. Lee S., Sato Y., Nixon R.A. Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J. Neurosci. 2011, 31:7817-7830.
44. Lee W.C., Yoshihara M., Littleton J.T. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3224-3229.
45. Li L., Cheung T., Chen J., Herrup K. A comparative study of five mouse models of Alzheimer's disease: cell cycle events reveal new insights into neurons at risk for death. Int. J. Alzheimers Dis. 2011, 2011:171464.
46. Li S.H., Gutekunst C.A., Hersch S.M., Li X.J. Interaction of huntingtin-associated protein with dynactin P150Glued. J. Neurosci. 1998, 18:1261-1269.
47. Mandelkow E.M., Stamer K., Vogel R., Thies E., Mandelkow E. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol. Aging 2003, 24:1079-1085.
48. Matsuda S., Matsuda Y., D'Adamio L. Amyloid beta protein precursor (AbetaPP), but not AbetaPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1. J. Biol. Chem. 2003, 278:38601-38606.
49. Morfini G., Pigino G., Beffert U., Busciglio J., Brady S.T. Fast axonal transport misregulation and Alzheimer's disease. Neuromol. Med. 2002, 2:89-99.
50. Morfini G., Pigino G., Brady S.T. Polyglutamine expansion diseases: failing to deliver. Trends Mol. Med. 2005, 11:64-70.
51. Morfini G., Pigino G., Szebenyi G., You Y., Pollema S., Brady S.T. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 2006, 9:907-916.
52. Morfini G.A., Burns M., Binder L.I., Kanaan N.M., LaPointe N., Bosco D.A., Brown R.H., Brown H., Tiwari A., Hayward L., et al. Axonal transport defects in neurodegenerative diseases. J. Neurosci. 2009, 29:12776-12786.
53. Morfini G.A., You Y.M., Pollema S.L., Kaminska A., Liu K., Yoshioka K., Bjorkblom B., Coffey E.T., Bagnato C., Han D., et al. Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat. Neurosci. 2009, 12:864-871.
54. Muresan V., Muresan Z. Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer's disease?. Future Neurol. 2009, 4:761-773.
55. Muresan V., Varvel N.H., Lamb B.T., Muresan Z. The cleavage products of amyloid-beta precursor protein are sorted to distinct carrier vesicles that are independently transported within neurites. J. Neurosci. 2009, 29:3565-3578.
56. Muresan Z., Muresan V. Coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1. J. Cell Biol. 2005, 171:615-625.
57. Muresan Z., Muresan V. Neuritic deposits of amyloid-beta peptide in a subpopulation of central nervous system-derived neuronal cells. Mol. Cell. Biol. 2006, 26:4982-4997.
58. Nakata T., Hirokawa N. Microtubules provide directional cues for polarized axonal transport through interaction with kinesin motor head. J. Cell Biol. 2003, 162:1045-1055.
59. Nikolaev A., McLaughlin T., O'Leary D.D., Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009, 457:981-989.
60. Papp H., Pakaski M., Kasa P. Presenilin-1 and the amyloid precursor protein are transported bidirectionally in the sciatic nerve of adult rat. Neurochem. Int. 2002, 41:429-435.
61. Pigino G., Morfini G., Pelsman A., Mattson M.P., Brady S.T., Busciglio J. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J. Neurosci. 2003, 23:4499-4508.
62. Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., et al. Mutant dynactin in motor neuron disease. Nat. Genet. 2003, 33:455-456.
63. Qiang L., Fujita R., Yamashita T., Angulo S., Rhinn H., Rhee D., Doege C., Chau L., Aubry L., Vanti W.B., et al. Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons. Cell 2011, 146:359-371.
64. Reid E., Kloos M., Ashley-Koch A., Hughes L., Bevan S., Svenson I.K., Graham F.L., Gaskell P.C., Dearlove A., Pericak-Vance M.A., et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am. J. Hum. Genet. 2002, 71:1189-1194.
65. Rui Y., Tiwari P., Xie Z., Zheng J.Q. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J. Neurosci. 2006, 26:10480-10487.
66. Rusu P., Jansen A., Soba P., Kirsch J., Lower A., Merdes G., Kuan Y.H., Jung A., Beyreuther K., Kjaerulff O., et al. Axonal accumulation of synaptic markers in APP transgenic Drosophila depends on the NPTY motif and is paralleled by defects in synaptic plasticity. Eur. J. Neurosci. 2007, 25:1079-1086.
67. Salehi A., Delcroix J.D., Belichenko P.V., Zhan K., Wu C., Valletta J.S., Takimoto-Kimura R., Kleschevnikov A.M., Sambamurti K., Chung P.P., et al. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 2006, 51:29-42.
68. Sannerud R., Declerck I., Peric A., Raemaekers T., Menendez G., Zhou L., Veerle B., Coen K., Munck S., De Strooper B., et al. ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1. Proc. Natl. Acad. Sci. U. S. A. 2011.
69. Sapp E., Penney J., Young A., Aronin N., Vonsattel J.P., DiFiglia M. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J. Neuropathol. Exp. Neurol. 1999, 58:165-173.
70. Satpute-Krishnan P., DeGiorgis J.A., Conley M.P., Jang M., Bearer E.L. A peptide zipcode sufficient for anterograde transport within amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16532-16537.
71. Shah S.B., Nolan R., Davis E., Stokin G.B., Niesman I., Canto I., Glabe C., Goldstein L.S. Examination of potential mechanisms of amyloid-induced defects in neuronal transport. Neurobiol. Dis. 2009, 36:11-25.
72. Sheng J.G., Price D.L., Koliatsos V.E. The beta-amyloid-related proteins presenilin 1 and BACE1 are axonally transported to nerve terminals in the brain. Exp. Neurol. 2003, 184:1053-1057.
73. Simons M., Ikonen E., Tienari P.J., Cid-Arregui A., Monning U., Beyreuther K., Dotti C.G. Intracellular routing of human amyloid protein precursor: axonal delivery followed by transport to the dendrites. J. Neurosci. Res. 1995, 41:121-128.
74. Sinadinos C., Burbidge-King T., Soh D., Thompson L.M., Marsh J.L., Wyttenbach A., Mudher A.K. Live axonal transport disruption by mutant huntingtin fragments in Drosophila motor neuron axons. Neurobiol. Dis. 2009, 34:389-395.
75. Smith K.D., Kallhoff V., Zheng H., Pautler R.G. In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage 2007, 35:1401-1408.
76. Smith K.D., Paylor R., Pautler R.G. R-flurbiprofen improves axonal transport in the Tg2576 mouse model of Alzheimer's Disease as determined by MEMRI. Magn. Reson. Med. 2011 May, 65(5):1423-1429.
77. Smith K.D., Peethumnongsin E., Lin H., Zheng H., Pautler R.G. Increased human wildtype tau attenuates axonal transport deficits caused by loss of APP in mouse models. Magn. Reson. Insights 2010, 4:11-18.
78. Stokin G.B., Almenar-Queralt A., Gunawardena S., Rodrigues E.M., Falzone T., Kim J., Lillo C., Mount S.L., Roberts E.A., McGowan E., et al. Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. Hum. Mol. Genet. 2008, 17:3474-3486.
79. Stokin G.B., Goldstein L.S. Axonal transport and Alzheimer's disease. Annu. Rev. Biochem. 2006, 75:607-627.
80. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307:1282-1288.
81. Szebenyi G., Morfini G.A., Babcock A., Gould M., Selkoe K., Stenoien D.L., Young M., Faber P.W., MacDonald M.E., McPhaul M.J., et al. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 2003, 40:41-52.
82. Takashima A., Yamaguchi H., Noguchi K., Michel G., Ishiguro K., Sato K., Hoshino T., Hoshi M., Imahori K. Amyloid beta peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3 beta in rat hippocampal neurons. Neurosci. Lett. 1995, 198:83-86.
83. Terry R.D. The cytoskeleton in Alzheimer disease. J. Neural Transm. Suppl. 1998, 53:141-145.
84. Torroja L., Chu H., Kotovsky I., White K. Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport. Curr. Biol. 1999, 9:489-492.
85. Trushina E., Dyer R.B., Badger J.D., 2nd Ure D., Eide L., Tran D.D., Vrieze B.T., Legendre-Guillemin V., McPherson P.S., Mandavilli B.S., et al. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol. Cell. Biol. 2004, 24:8195-8209.
86. Twelvetrees A.E., Yuen E.Y., Arancibia-Carcamo I.L., MacAskill A.F., Rostaing P., Lumb M.J., Humbert S., Triller A., Saudou F., Yan Z., et al. Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron 2010, 65:53-65.
87. Vossel K.A., Zhang K., Brodbeck J., Daub A.C., Sharma P., Finkbeiner S., Cui B., Mucke L. Tau reduction prevents Abeta-induced defects in axonal transport. Science 2010, 330:198.
88. Wang X., Perry G., Smith M.A., Zhu X. Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegener. Dis. 2010, 7:56-59.
89. Weisz O.A., Rodriguez-Boulan E. Apical trafficking in epithelial cells: signals, clusters and motors. J. Cell Sci. 2009, 122:4253-4266.
90. Zala D., Colin E., Rangone H., Liot G., Humbert S., Saudou F. Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum. Mol. Genet. 2008, 17:3837-3846.